Skip to Content

Panacos Pharmaceuticals Inc PANC

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PANC is trading at a 55% discount.
Price
$0.00
Fair Value
$4.49
Uncertainty
Extreme
1-Star Price
$5.13
5-Star Price
Economic Moat
Khx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PANC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
/
Market Cap
$53.64
Volume/Avg
1,000 / 1,579

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
41

Valuation

Metric
PANC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PANC
Quick Ratio
2.11
Current Ratio
2.15
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
PANC
Return on Assets (Normalized)
−80.01%
Return on Equity (Normalized)
−169.75%
Return on Invested Capital (Normalized)
−93.92%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRHznp$550.4 Bil
VRTX
Vertex Pharmaceuticals IncMbtkwlf$111.8 Bil
REGN
Regeneron Pharmaceuticals IncRhrzs$107.9 Bil
MRNA
Moderna IncPlh$36.3 Bil
ARGX
argenx SE ADRFgnj$23.0 Bil
BNTX
BioNTech SE ADRJnv$21.6 Bil
ALNY
Alnylam Pharmaceuticals IncCmlcnnz$19.2 Bil
BMRN
Biomarin Pharmaceutical IncHkdvhb$16.4 Bil
RPRX
Royalty Pharma PLC Class AYtchyn$13.4 Bil
INCY
Incyte CorpCvggm$13.3 Bil

Sponsor Center